VCP
BME icon

Verus Capital Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Verus Capital Partners’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$8K Buy
220
+3
+1% +$120 ﹤0.01% 1059
2019
Q4 		$9K Buy
+217
New +$8.61K ﹤0.01% 1167

Other funds holding BME

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Verus Capital Partners's BME Position: Q1 2020 in Review

Verus Capital Partners increased its BlackRock Health Sciences Trust (BME) stake by 1.4% in Q1 2020, buying an estimated $120 and bringing the position to 220 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

Verus Capital Partners first reported a position in BME in Q4 2019 and has held it in 2 quarters since. The position peaked at $9K in Q4 2019. 41 funds tracked by Wall St. Rank hold BME as of Q1 2020.

  • Verus Capital Partners held 220 shares of BlackRock Health Sciences Trust worth $8K as of Q1 2020.
  • Verus Capital Partners bought 3 BlackRock Health Sciences Trust shares in Q1 2020, an estimated $120.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1059 holding.
  • Verus Capital Partners first reported a position in BlackRock Health Sciences Trust in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's BlackRock Health Sciences Trust position peaked at $9K in Q4 2019.
  • 41 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.